DHA Support for banning Tianeptine (HB 21)

DHA sent a letter of support to Rep. Kim Williams regarding House Bill 21, legislation that would classify Tianeptine as a schedule 1 controlled substance and bans its sale in Delaware.

Click here to read the letter.